Big ideas change the world. Entrepreneurship education is the core mission of the Grid. Through our M.S. Health and Social Innovation and accompanying certificates, we help students become entrepreneurial thinkers and doers. We work with students to create ideas, test out innovations, and bring ideas to market.
Have a big idea to change the world? The Masters of Science in Health and Social Innovation challenges students to explore and apply principles of innovation, entrepreneurship, and design thinking to solve complex health and social challenges. Apply now!
By the end of this program students will be able to launch their own start-ups, examine and impact innovation within existing organizations, and understand how change can be realized by examining policy and regulations. There are three concentrations: Health Science, User Experience (UX), and Biomedical Entrepreneurship. Through these concentrations, students will be equipped to tackle different health and social challenges of their choosing with a core curriculum steeped in methods of design thinking, principles of business, and market research.
Classes for the MS Health and Social Innovation Program will be both in person and online. In person classes will be housed at the University of Maryland's newest innovation hub, the Graduate Research Innovation District (the Grid). Located at the University's BioPark, the Grid is an innovation space where students, entrepreneurs, faculty, and staff connect to bring innovative health and social impact ideas to life.
This unique 12-credit graduate certificate program will educate students to engage with and respond to civic, social, environmental, medical, and economic challenges at the local, national, and global levels.
Students will learn how to search, interpret, and evaluate the medical and public health literature; including qualitative and quantitative studies. They will examine and critically appraise healthcare delivery systems and health policy at the local and global level; discuss and inform health care delivery, patient safety, quality, and risk management; and articulate and explain principles and practice of medical and public health ethics.
Applications for admission for the Fall 2019 term will be open soon.
This unique 15-credit graduate certificate provides students with an opportunity to learn technology development and commercialization skills in the real world environment that combines theory and practice.
In this certificate, which is a partnership with the University of Maryland School of Medicine, students experience the entire spectrum of the commercialization process: taking ideas from their life sciences bench research through invention, product development, technical and market feasibility analysis, intellectual property acquisition and protection, business design, and venture funding, while experiencing what is required to become a stakeholder in a new technology venture.
This unique 12-credit graduate certificate will provide students with knowledge on how to use research and principles from design, psychology, business, and computing to create technology that not only solves problems, but also intuitive, functional, and enjoyable use.
The User Experience concentration is a collaboration with the University of Baltimore. User experience or UX, encompasses all aspects of the end-user's interaction with the company, its services, and its products. Students will learn how to promote a user experience that balances the goals of businesses, the demands of content and the needs of users, become familiar with requirements analysis, information design and delivery, usability testing and Web-based application development, and develop, design, and produce a range of electronic information resources. All courses in the UX Certificate will be taken at University of Baltimore.
- To learn methods to evaluate life science based technology and intellectual property as basis of new venture creation
- To study the knowledge, skills and attitudes required for entrepreneurship
- To evaluate market, operational and financial feasibility of venture formation
- To learn basic business planning and financial planning skills
- To network with life science entrepreneurs
- To provide students with the skills for identifying and analyzing entrepreneurial opportunities throughout their career
Statement of Confidentiality
Throughout the course, students will be exposed to proprietary information from other students, guest lecturers and faculty. All such information is to be treated as confidential. By enrolling in and taking part in this course, students agree not to disclose this information to any third parties without the specific written permission from students, guest lecturers or faculty as applicable. Students further agree not to utilize any such proprietary information for their own personal commercial advantage or for the commercial advantage of any third party. In additions, students agree that any advice provided by the instructor and any affiliated parties will not serve as the basis on any legal suit. Any breach of this policy may subject a student to academic integrity proceedings as described in the University of Maryland policies and procedures, and to any remedies that may be available at law. Receipt of this policy and registration in our classes is evidence that you understand this policy and will abide by it.
Register on the SURFS website at www.umaryland.edu/surfs
CRN Number 26474
- “Technology Ventures” by Richard C. Dorf and Thomas H. Byers. 1st or 2nd edition is the optional text. Listed as Dorf & Byers in the schedule.
- Articles and readings as assigned
- Interim assignments (5% per sub-item) 25%
- Concept submission (team)
- Market and competitive analysis (team)
- Regulatory, ethics and operations statement (team)
- Marketing plan (team)
- Financial statements (team)
- Business Plan (team) 25%
- Investor Presentation (team) 20%
- Class participation (individual) 10%
- Peer evaluation (individual) 10%
- Investor feedback (individual) 10%
Instructor - Rana Quraishi, PhD
Professional Background and Experience
Director of New Ventures UMB
- Create startups from appropriate University IP, develop business strategy and function as senior management at startups and obtain funding.
- Developed UMB’s New Venture Initiative (NVI) approved by Board of Regents
- Manage NVI team and consultants
- Maintain extensive relationships with major national venture firms, angel groups, and external innovation teams at pharma companies
- Run Presidential Entrepreneurial Fellowship program
- Senior Advisor at TCG Group, a premiere private equity firm focused on business development opportunities for its life science companies
- Principal at Conning Capital Partners/SwissRe an early stage private equity fund providing growth capital for entrepreneurial companies - served on Boards of several portfolio companies.
- CFO/senior advisor for Helicon Therapeutics, a start-up with assets contributed by Cold Spring Harbor and OSI Pharmaceuticals - developed business plan, obtained full funding for plan.
- Senior roles in acquisitions, treasury and risk at Standard and Poor’s, GE Capital, J.E. Seagram and American Express
- Authored “Market Demand Study for Commercial Biotechnology, Biomedical, and Bioinformatics Facilities in New York City” for New York City Partnership and Investment Fund.
- Taught Biochemistry and Genetics at Columbia University during PhD, subsequently guest lecturer at academic institutions
- PhD in Molecular Biology and Biochemistry - Columbia University, BA - Columbia (Barnard), Master Degree - Harvard University.